Brazil's national regulator, Anvisa, will open a public consultation on establishing quality requirements for pharmaceutical excipients used in the manufacture of medicinal products. Excipients include additives such as diluents, flavoring agents and antioxidants.

The Public Consultation No. 31, published 28 May, provides for 60 days of comment beginning June 4 2012.  Comments can be submitted using the Ministry of Health's electronic system, FormSUS.

Read more:

Public Consultation No. 31

More Breaking News from RegLink